NVIDIA has introduced the BioNeMo Agent Toolkit, a specialized framework designed to transform general-purpose artificial intelligence agents into capable AI scientists for life science discovery. While large language models excel at code generation and literature analysis, biomolecular research presents unique challenges: hypotheses are iterative, uncertain, and deeply dependent on precise physical and computational validation. General coding agents lack the domain-specific instrumentation to reliably execute complex biological workflows. BioNeMo addresses this gap by converting NVIDIA accelerated digital biology into standardized, agent-callable tools. The platform operates through two primary layers. First, an accelerated tool layer leverages NVIDIA NIM and open-source models to deliver core biomolecular capabilities, including structure prediction, molecular docking, sequence design, and genomics analysis. These models are optimized using specialized libraries such as cuEquivariance for structural AI and Parabricks for high-throughput genomics. Second, BioNeMo Skills packages and Model Context Protocol wrappers translate these capabilities into structured, agent-ready interfaces. Each skill defines a model purpose, required inputs, optional parameters, expected file formats, and known failure modes, enabling AI agents to select appropriate tools, construct valid requests, and interpret outputs without manual configuration. Deployment flexibility is a core architectural principle. Teams can initially route agent workloads to hosted NIM endpoints for rapid prototyping, broad access, and infrastructure-free scaling. As workflows mature or require lower latency, tighter data governance, or high-frequency iteration, models can be migrated to local deployments. Internal testing demonstrates that local hosting significantly reduces warm-up latency for repeated inference loops, while hosted endpoints remain optimal for exploratory calls and heavy compute tasks like multiple sequence alignment. Performance benchmarks conducted using Codex CLI and GPT-5.5 fast highlight the toolkit operational impact. When equipped with BioNeMo Skills, AI agents achieved a 100 percent task completion rate, a substantial increase from a 57.1 percent baseline without specialized tools. Token efficiency also improved by an average of two times, as structured interfaces reduced redundant prompts, parameter adjustments, and failed inference attempts. Evaluation metrics focused on both accuracy, verifying correct model selection and valid input formatting, and efficiency, measuring single-call latency, parameter-sweep throughput, and overall computational overhead. The framework is designed to be agnostic to underlying language models, allowing seamless integration with third-party agent orchestrators. NVIDIA also notes that BioNeMo architecture extends naturally to broader research workflows when paired with the Nemotron and NeMo Agent Toolkit for memory management and multi-step orchestration. By standardizing access to accelerated biomolecular AI, the BioNeMo Agent Toolkit shifts molecular research from isolated model executions to continuous, self-correcting scientific loops. Developers can begin integration through the publicly available toolkit repository, marking a step toward operationalizing autonomous discovery in drug design, protein engineering, and genomic analysis.